Abiomed
ABMD
$381.02
Share price
0.00%
Change (1 day)
55.18%
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the world’s smallest heart pump.
Operating Margin for Abiomed (ABMD)
Operating Margin as of September 2023 (TTM): 31.76%
According to Abiomed's latest financial reports and stock price the company's current Operating Margin is 31.76%. At the end of 2022 the company had an Operating Margin of 18.47%.
Operating Margin history for Abiomed from 2013 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 18.47% | -45.69% |
| 2021 | 34.01% | 11.35% |
| 2020 | 30.54% | -10.77% |
| 2019 | 34.23% | 26.67% |
| 2018 | 27.02% | 31.73% |
| 2017 | 20.51% | 2.67% |
| 2016 | 19.98% | 59.96% |
| 2015 | 12.49% | 168.89% |
| 2014 | 4.64% | -56.44% |
| 2013 | 10.66% | 429.94% |
| 2012 | 2.01% | -118.74% |
| 2011 | -10.74% | -49.84% |
| 2010 | -21.41% | -49.18% |
| 2009 | -42.13% | -38.54% |
| 2008 | -68.55% | 26.68% |
| 2007 | -54.11% | -18.78% |
| 2006 | -66.62% | 682.65% |
| 2005 | -8.51% | -78.63% |
| 2004 | -39.83% | -52.37% |
| 2003 | -83.62% | -8.79% |
| 2002 | -91.67% | 29.96% |
| 2001 | -70.54% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Boston Scientific BSX | 11.27% | -64.52% | 🇺🇸 USA |
 Teleflex TFX | 15.97% | -49.72% | 🇺🇸 USA |
 AtriCure ATRC | -13.98% | -144.02% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.